JP2019513136A - 羊水による治療の組成物及び方法 - Google Patents

羊水による治療の組成物及び方法 Download PDF

Info

Publication number
JP2019513136A
JP2019513136A JP2018549837A JP2018549837A JP2019513136A JP 2019513136 A JP2019513136 A JP 2019513136A JP 2018549837 A JP2018549837 A JP 2018549837A JP 2018549837 A JP2018549837 A JP 2018549837A JP 2019513136 A JP2019513136 A JP 2019513136A
Authority
JP
Japan
Prior art keywords
composition
amniotic fluid
modified
pharmaceutically acceptable
acceptable carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018549837A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019513136A5 (enExample
Inventor
ジェイ． クーブ，トマス
ジェイ． クーブ，トマス
マッシー，ミッシェル
Original Assignee
ミメディクス グループ インコーポレイテッド
ミメディクス グループ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ミメディクス グループ インコーポレイテッド, ミメディクス グループ インコーポレイテッド filed Critical ミメディクス グループ インコーポレイテッド
Publication of JP2019513136A publication Critical patent/JP2019513136A/ja
Publication of JP2019513136A5 publication Critical patent/JP2019513136A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Vascular Medicine (AREA)
  • Birds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
JP2018549837A 2016-03-23 2017-03-23 羊水による治療の組成物及び方法 Pending JP2019513136A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201662312391P 2016-03-23 2016-03-23
US201662312379P 2016-03-23 2016-03-23
US201662312403P 2016-03-23 2016-03-23
US62/312,391 2016-03-23
US62/312,403 2016-03-23
US62/312,379 2016-03-23
PCT/US2017/023893 WO2017165698A1 (en) 2016-03-23 2017-03-23 Compositions and methods of treatment with amniotic fluid

Publications (2)

Publication Number Publication Date
JP2019513136A true JP2019513136A (ja) 2019-05-23
JP2019513136A5 JP2019513136A5 (enExample) 2020-04-30

Family

ID=59899764

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018549837A Pending JP2019513136A (ja) 2016-03-23 2017-03-23 羊水による治療の組成物及び方法

Country Status (5)

Country Link
US (2) US10960027B2 (enExample)
EP (1) EP3432896A4 (enExample)
JP (1) JP2019513136A (enExample)
AU (2) AU2017237093B2 (enExample)
WO (1) WO2017165698A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
US20190167862A1 (en) * 2015-03-04 2019-06-06 Pensara, Inc Collection of amniotic fluid for wound healing
JP2019513136A (ja) * 2016-03-23 2019-05-23 ミメディクス グループ インコーポレイテッド 羊水による治療の組成物及び方法
US20170354692A1 (en) * 2016-06-13 2017-12-14 MAM Holdings of West Florida, L.L.C. Amniotic fluid formulation for treatment of lung disorders
US10869953B2 (en) 2018-12-13 2020-12-22 James Glenn Norman Shield for recurrent laryngeal nerve and associated methods
US10342631B1 (en) * 2018-12-13 2019-07-09 James Glenn Norman Shield for recurrent laryngeal nerve and associated method of use
US10933164B2 (en) 2018-12-13 2021-03-02 James Glenn Norman Methods for protecting a parathyroid
EP3930734A4 (en) * 2019-02-28 2022-12-07 Merakris Therapeutics, LLC EXTRACELLULAR VESICLES DERIVED FROM AMBIENT WATER AND THEIR USES IN WOUND HEALING
JP7099714B2 (ja) * 2019-04-25 2022-07-12 株式会社グランツーク研究所 噴霧用美容液
TR201917367A2 (tr) * 2019-11-08 2021-05-21 Ercuement Ovali Saç dökülmesi̇ ve skar tedavi̇si̇nde kullanima uygun bi̇r ürünün üreti̇mi̇ i̇çi̇n bi̇r yöntem
US12377121B2 (en) * 2020-04-10 2025-08-05 Zeo Scientifix, Inc. Compositions comprising nanoparticles, method of making and uses thereof
US11485451B2 (en) 2021-02-03 2022-11-01 Jetts, Llc Jet sled
WO2022236015A1 (en) * 2021-05-07 2022-11-10 Regenerative Science, Inc. Amniotic cytokine formulations
US12213994B2 (en) 2021-12-08 2025-02-04 Zeo Scientifix, Inc. Compositions and methods for treating pain with extracellular vesicles
WO2024206871A1 (en) * 2023-03-30 2024-10-03 Cetel Scientific Llc Amniotic and chorionic collagen for ocular surface healing
WO2025034980A1 (en) * 2023-08-08 2025-02-13 Mimedx Group, Inc. Pourable placental collagen matrix sheet

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5251010A (en) * 1975-10-22 1977-04-23 Morinaga Milk Ind Co Ltd Method of producing drug for treating marrow
US20080286378A1 (en) * 2005-02-22 2008-11-20 Ashley Behrens Use of Amniotic Fluid (Af) in Treating Ocular Disease and Injury
JP2013233194A (ja) * 2012-05-07 2013-11-21 Hidenobu Ota 早産児用の抱っこ型次世代人工保育器。
US20150025366A1 (en) * 2013-05-10 2015-01-22 Carl Randall Harrell Method for Obtaining Sterile Human Amniotic Fluid and Uses Thereof
WO2015134946A1 (en) * 2014-03-06 2015-09-11 Amnio Technology Llc Amnion derived therapeutic compositions and methods of use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1696958A (en) * 1927-03-02 1929-01-01 Herbert L Johnson Therapeutic agent for treatment of bodily lesions
US3689668A (en) * 1967-10-18 1972-09-05 Emile Leon Piette Method of alleviating wrinkles on skin
US20120276215A1 (en) * 2011-04-26 2012-11-01 Riordan Neil H Therapeutic Conditioned Media
US8932805B1 (en) * 2011-10-31 2015-01-13 BioDlogics, LLC Birth tissue material and method of preparation
US20140336600A1 (en) 2013-05-10 2014-11-13 Carl Randall Harrell Method for Obtaining Sterile Human Amniotic Fluid and Uses Thereof
KR20160147058A (ko) * 2014-05-07 2016-12-21 오시리스 쎄라퓨틱스, 인크. 치료적 태반 조성물, 이의 제조방법 및 사용방법
US20160000968A1 (en) * 2014-07-07 2016-01-07 Mimedx Group, Inc. Placental tissue grafts and improved methods of preparing and using the same
US20160067287A1 (en) * 2014-09-09 2016-03-10 Mimedx Group, Inc. Micronized placental tissue compositions with optional sealant and methods of making and using the same
US11129856B2 (en) 2015-03-03 2021-09-28 Prime Merger Sub, Llc Methods of treating chronic wounds with amniotic fluid having elevated levels of tissue inhibitors of matrix metalloproteinases
US11077149B1 (en) * 2015-03-04 2021-08-03 Pensara, Inc Method for the collection and use of amniotic fluid
MA45272A (fr) 2015-06-27 2018-05-02 Stimlabs Llc Produits issus de liquide amniotique et procédés d'utilisation
US10413572B2 (en) 2015-08-11 2019-09-17 Vivex Biomedical, Inc. Liquid amnion transplant product
US10517903B2 (en) 2015-09-14 2019-12-31 Amnio Technology Llc Amnion derived therapeutic composition and process of making same
JP2019513136A (ja) * 2016-03-23 2019-05-23 ミメディクス グループ インコーポレイテッド 羊水による治療の組成物及び方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5251010A (en) * 1975-10-22 1977-04-23 Morinaga Milk Ind Co Ltd Method of producing drug for treating marrow
US20080286378A1 (en) * 2005-02-22 2008-11-20 Ashley Behrens Use of Amniotic Fluid (Af) in Treating Ocular Disease and Injury
JP2013233194A (ja) * 2012-05-07 2013-11-21 Hidenobu Ota 早産児用の抱っこ型次世代人工保育器。
US20150025366A1 (en) * 2013-05-10 2015-01-22 Carl Randall Harrell Method for Obtaining Sterile Human Amniotic Fluid and Uses Thereof
WO2015134946A1 (en) * 2014-03-06 2015-09-11 Amnio Technology Llc Amnion derived therapeutic compositions and methods of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
なずなの塩を訪ねて, 絵本フォーラム, 2005-05-10, [検索日 2022-11-10],<HTTPS://WWW.EHONDEKOSODATE.COM, JPN6022048587, ISSN: 0005056580 *

Also Published As

Publication number Publication date
AU2017237093A1 (en) 2018-10-18
AU2023201219A1 (en) 2023-04-06
US11865142B2 (en) 2024-01-09
EP3432896A1 (en) 2019-01-30
AU2017237093B2 (en) 2022-12-01
WO2017165698A1 (en) 2017-09-28
EP3432896A4 (en) 2020-01-15
US10960027B2 (en) 2021-03-30
US20200129562A1 (en) 2020-04-30
US20210283190A1 (en) 2021-09-16

Similar Documents

Publication Publication Date Title
US11865142B2 (en) Compositions and methods of treatment with amniotic fluid
Sahu et al. Utility of nanomaterials in wound management
US12453743B2 (en) Mesenchymal stem cell (MSC) growth factor and extracellular vesicle preparation in frozen or powdered form and methods of use
CN111848832B (zh) 含氟化合物修饰的阳离子聚合物作为药物载体的应用及制备方法
KR101004551B1 (ko) 조직유착 방지액 및 조직유착 방지방법
CN104981258B (zh) 用于组织再生的组合物、其制备方法及其用途
EP2926819B1 (en) Method for initiating stem cells of mammals and use of chlorine dioxide in preparation of drug for initiating stem cells of mammals
WO2008037262A1 (en) Wound healing composition comprising phosphate, iron and copper
CN108135965B (zh) 用于伤口愈合的含p物质的药物组合物
CN103933603A (zh) 一种壳聚糖促人表皮生长生物医用胶及其制备方法
ES2755055T3 (es) Composición para el tratamiento de lesiones tisulares
KR20200030022A (ko) 하이드로젤 패치를 포함하는 상처 또는 흉터 치료용 조성물
CN107446018B (zh) 促进伤口愈合的肽及其应用
CN107961232B (zh) 药物调配物和其用途
CA2966724C (en) Biological film-forming agent for facilitation of wound healing and coating and protection of biological organs
TW202502805A (zh) 新多功能寡肽
EA001308B1 (ru) Средство, обладающее противовоспалительным, антисептическим и регенераторным действием
RU2173155C1 (ru) Ранозаживляющий, противовоспалительный и противоинфекционный лекарственный препарат
CN115137751B (zh) 一种富血小板血浆的处理方法及其在抑制妊娠纹中的应用
WO2025087269A1 (en) New short-chain peptides and derivatives thereof
Chen et al. Burn wound care
HK40082364A (en) Topical formulations comprising combinations of montelukast and mussel adhesion proteins
WO2025097220A1 (en) Composition
RU2271218C2 (ru) Способ местного лечения папилломавирусной инфекции урогенитального тракта у женщин
TW201023878A (en) Non-surgical improvement of scars

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200323

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200323

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210323

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210618

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210820

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220104

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220328

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220601

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220630

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220701

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20221115

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230315

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20230315

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20230328

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230419

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20230425

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20230519